- Research Article
1
- 10.1016/j.jaci.2025.03.015
Immunogenicity of adjuvanted recombinant SARS-CoV-2 spike protein vaccine after earlier mRNA vaccine doses.
- Jun 01, 2025
- The Journal of allergy and clinical immunology
- Jeffrey M Adelglass + 11 more +11
Publications from 2021 to 2026
Showing 4 of 4 papers
Immunogenicity of adjuvanted recombinant SARS-CoV-2 spike protein vaccine after earlier mRNA vaccine doses.
The Surface of Ionic Liquids in Water: From an Ionic Tug of War to a Quasi-Ordered Two-Dimensional Layer.
The sustainable development encompasses the search for new materials for energy storage, gas capture, separation, and solvents in industrial processes that can substitute conventional ones in an efficient and clean manner. Ionic liquids (ILs) emerged and have been advanced as alternative materials for such applications, but an obstacle is their hygroscopicity and the effects on their physical properties in the presence of humidity. Several industrial processes depend on the aqueous interfacial properties, and the main focus of this work is the water/IL interface. The behavior of the aqueous ionic liquids at the water-vacuum interface is representative for their water interfacial properties. Using X-ray photoelectron spectroscopy in combination with molecular dynamics simulations we investigate four aqueous IL systems, and provide molecular level insight on the interfacial behaviour of the ionic liquids, such as ion-pair formation, orientation and surface concentration. We find that ionic liquids containing a chloride anion have a lowered surface enrichment due to the low surface propensity of chloride. In contrast, the ionic liquids containing a bistriflimide anion are extremely surface-enriched due to cooperative surface propensity between the cations and anions, forming a two-dimensional ionic liquid on the water surface at low concentrations.
Read moreOverexpression of the plastidal pseudo-protease <i>AtFtsHi3</i> confers drought tolerance without penalizing growth
Abstract Drought is one of the most severe environmental stresses affecting plant biomass production and quality, however, the molecular mechanisms of drought response in plants remain unclear. Here, we demonstrate that overexpression of the Arabidopsis gene FTSHi3 under the influence of its endogenous, or the 35S constitutive promoter results in drought-tolerant phenotypes without penalising plant growth. FTSHi3 encodes a pseudo-protease located in the chloroplast envelope and knock-down mutants ( ftshi3-1 ) have previously been found to be drought tolerant, but highly reduced in growth. Changes in FtsHi3 transcript abundance therefore seems to induce drought tolerance in Arabidopsis thaliana . Overexpression of FTSHi3 ( pFTSHi3-OE ) impacts leaf stomatal density, lowers stomatal conductance and increases water use efficiency. To explore the underlying mechanisms behind this, we compared the proteomes of ftshi3-1 and pFTSHi3-OE to wild type plants grown under drought and watered conditions. Under drought conditions, the drought related processes ‘osmotic stress’, ‘water transport’ and ‘response to abscisic acid’ were enriched, indicating that pFtsHi3-OE and ftshi3-1 mutants are more active in their response to drought than the wild-type. The proteins HSP90, HSP93 and TIC110 were more abundant in the knock-down mutant, which suggests that FtsHi3 might play a downstream role in chloroplast pre-protein import. Increased abundance of FtsH7/9 and FtsH11, FtsH12 and FtsHi4 in ftshi3-1 combined with the fact that FtsH proteases function as homo- or heteromeric complexes suggests that these proteases may be possible interacting partners. To explore this, we constructed mathematical models that show FtsHi3 likely interacts with at least two other (pseudo-) proteases.
Read morePhase I assessments of first-in-human administration of a novel malaria anti-sporozoite vaccine candidate, R21 in matrix-M adjuvant, in UK and Burkinabe volunteers
ABSTRACTBackgroundImprovements in malaria control have stalled recently and new tools are needed. The R21 vaccine is comprised of the malaria circumsporozoite protein fused to hepatitis B surface antigen (HBsAg). It forms particles that lack the excess HBsAg in the frequently tested malaria vaccine candidate, RTS,S/AS01B.MethodsWe conducted an open-label, first-in-human, Phase Ia study evaluating safety and immunogenicity of R21 administered alone and with the saponin-based adjuvant, Matrix-M™ (MM). Twenty-eight healthy adults received three doses of R21 given intramuscularly 4 weeks apart. We subsequently conducted a Phase Ib randomised, controlled trial in West African adults.FindingsVaccinations were well tolerated, and the majority of local and systemic adverse events were mild. Reactogenicity was significantly lower in Burkinabe than UK vaccinees (p<0.0001). Antibody responses increased significantly 28 days after the 2nd vaccination in UK volunteers. Antibody responses to R21 in all dose groups (2μg, 10μg and 50μg) were comparable to those of 50μg RTS,S/AS01B in malaria-naïve adults at 28 days after final vaccination. The 10μg dose induced more durable responses, with 2-fold higher NANP-specific IgG titres at 6 months compared with the 2μg and 50μg dose groups. R21 also boosted baseline humoral responses in Burkinabe adults with well-maintained responses suggesting natural boosting.InterpretationR21 adjuvanted with MM is safe and has comparable immunogenicity to RTS,S/AS01B, even when administered at a five-fold lower 10μg dose in UK and African populations. This forms the basis for efficacy testing of this vaccine which could prove to be particularly cost-effective to manufacture and deploy.
Read more